148 related articles for article (PubMed ID: 23142283)
1. MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy.
Zhang JX; Qian D; Wang FW; Liao DZ; Wei JH; Tong ZT; Fu J; Huang XX; Liao YJ; Deng HX; Zeng YX; Xie D; Mai SJ
Cancer Lett; 2013 Feb; 329(1):91-8. PubMed ID: 23142283
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
[TBL] [Abstract][Full Text] [Related]
4. microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.
Yuan TZ; Zhang HH; Lin XL; Yu JX; Yang QX; Liang Y; Deng J; Huang LJ; Zhang XP
Mol Med Rep; 2017 Apr; 15(4):2223-2228. PubMed ID: 28260044
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells.
Han Q; Li L; Liang H; Li Y; Xie J; Wang Z
Med Sci Monit; 2017 Oct; 23():4798-4807. PubMed ID: 28985197
[TBL] [Abstract][Full Text] [Related]
6. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
Liu N; Tang LL; Sun Y; Cui RX; Wang HY; Huang BJ; He QM; Jiang W; Ma J
Cancer Lett; 2013 Feb; 329(2):181-8. PubMed ID: 23142282
[TBL] [Abstract][Full Text] [Related]
7. miR-29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1.
Huang L; Hu C; Chao H; Wang R; Lu H; Li H; Chen H
Exp Cell Res; 2019 May; 378(1):1-10. PubMed ID: 30779921
[TBL] [Abstract][Full Text] [Related]
8. MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma.
Niu M; Gao D; Wen Q; Wei P; Pan S; Shuai C; Ma H; Xiang J; Li Z; Fan S; Li G; Peng S
BMC Cancer; 2016 Mar; 16():218. PubMed ID: 26975503
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NEAT1/miR-129/Bcl-2 signaling axis contributes to HDAC inhibitor tolerance in nasopharyngeal cancer.
Xue F; Cheng Y; Xu L; Tian C; Jiao H; Wang R; Gao X
Aging (Albany NY); 2020 Jul; 12(14):14174-14188. PubMed ID: 32692721
[TBL] [Abstract][Full Text] [Related]
10. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
11. Has‑miR‑125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53‑dependent manner by targeting p53 mRNA.
Chen JJ; Liu SX; Chen MZ; Zhao ZY
Mol Med Rep; 2015 Sep; 12(3):3569-3574. PubMed ID: 26017674
[TBL] [Abstract][Full Text] [Related]
12. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
Arechaga-Ocampo E; Lopez-Camarillo C; Villegas-Sepulveda N; Gonzalez-De la Rosa CH; Perez-Añorve IX; Roldan-Perez R; Flores-Perez A; Peña-Curiel O; Angeles-Zaragoza O; Rangel Corona R; Gonzalez-Barrios JA; Bonilla-Moreno R; Del Moral-Hernandez O; Herrera LA; Garcia-Carranca A
Tumour Biol; 2017 Mar; 39(3):1010428317695010. PubMed ID: 28345453
[TBL] [Abstract][Full Text] [Related]
14. Exosome-derived microRNA-29c induces apoptosis of BIU-87 cells by down regulating BCL-2 and MCL-1.
Xu XD; Wu XH; Fan YR; Tan B; Quan Z; Luo CL
Asian Pac J Cancer Prev; 2014; 15(8):3471-6. PubMed ID: 24870742
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells.
Long Z; Wang B; Tao D; Huang Y; Tao Z
Int J Mol Med; 2014 Nov; 34(5):1388-94. PubMed ID: 25231528
[TBL] [Abstract][Full Text] [Related]
16. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
18. Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype.
Su Z; Li G; Liu C; Ren S; Tian Y; Liu Y; Qiu Y
Oncol Rep; 2016 Jul; 36(1):72-8. PubMed ID: 27108809
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.
Qu JQ; Yi HM; Ye X; Zhu JF; Yi H; Li LN; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Xiao ZQ
Mol Cancer Ther; 2015 Nov; 14(11):2653-64. PubMed ID: 26304234
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
Wang Y; Cheng N; Luo J
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
